In a pilot trial for metastatic prostate cancer using intermittent therapy, the median time to progression was 30 months, compared to 14 months for standard of care.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.